Bloomberg News

Shares of health device and equipment maker Medtronic  (MDT - Get Report) gained on Thursday after the company reported fiscal fourth-quarter earnings that beat analysts' forecasts and offered an upbeat assessment of its prospects for fiscal 2020.

Shares of Medtronic gained 2.25% to $90.76 in trading on the New York Stock Exchange after the company reported adjusted net income of $1.94 billion, or $1.42 a share, vs. $1.47 billion, or $1.07 a share, in the comparable year-earlier period. Analysts polled by FactSet had been expecting earnings of $1.46 a share.

However, sales rose to $8.15 billion the fiscal fourth quarter, up slightly from $8.14 billion a year earlier and above FactSet consensus estimates of $8.11 billion. 

For the full year Medtronic said it earned an adjusted $5.22 a share, above FactSet consensus estimates of $5.15. Full-year revenue came in at $30.56 billion vs. $29.95 billion.

$MDT chairman and CEO Omar Ishrak on Medtronic's Q4 2019 earnings results pic.twitter.com/8AAqnyXBB6

— Medtronic (@Medtronic) May 23, 2019

For fiscal year 2020, Medtronic said it expects per-share earnings of between $5.44 and $5.50, including a 10-cent negative impact from foreign exchange based on current rates. Analysts' current expectations are for full-year 2020 earnings of $5.44 a share. 

"The company continues to make significant progress on our pipeline," Medrtonic CEO Omar Ishrak said in a statement accompanying the earnings release. "We expect our revenue growth to accelerate over the course of fiscal year 2020 and into fiscal year 2021, driven by the anniversary of recent headwinds, combined with a series of major product launches over the next 12 months."

Jim Cramer and the Action Alerts Plus team are watching the Health Care Equipment & Supplies sector. To find out more about what stocks they like in the industry click here now to get more from Action Alerts PLUS.

Medtronic is a component of the Real Money Post-Industrial Average. To find out more about how you can profit from this and other Real Money premium products, please click here now.